Clinical Trial Update: Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide, prednisone, and cyclophosphamide in patients with myelofibrosis and myeloid metaplasia; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloproliferative Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Myeloproliferative Disorders, Secondary Myelofibrosis | Phase 2 | Status: COMPLETED